Compare Charles River Laboratories Intl. Inc (CRL) vs Electronic Arts Inc. (EA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Electronic Arts Inc. — how do they compare? Charles River Laboratories Intl. Inc trades at $227.69 (market cap $11.14B), while Electronic Arts Inc. trades at $207.68 (market cap $51.82B). The key difference: Electronic Arts Inc. is far larger — about 4.7× Charles River Laboratories Intl. Inc's market cap, and Electronic Arts Inc. pays a 0.37% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | EA | |
|---|---|---|
Market Cap | $11.14B | $51.82B |
Sector | Health | Technology |
52-Week High | $233.60 | $206.65 |
52-Week Low | $145.57 | $147.79 |
Enterprise Value | $14.00B | $50.39B |
Dividend Yield | — | 0.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
Electronic Arts (EA) trades at $206.35, down 0.03% on the day, with a bullish technical signal from moving averages and mixed earnings performance including a recent Q4 2025 beat. The company maintains strong profitability with a 78.97% gross margin and 11.78% net margin, though valuation ratios like P/E of 58.79 appear elevated. Recent launches of EA SPORTS College Football 27 and UFC 6, plus the new EA Advertising platform, highlight ongoing growth initiatives.
Outlook is cautiously optimistic given analyst consensus leaning Hold (56.06%) versus Buy (43.94%), with risks including earnings volatility and high valuation. The potential $55 billion acquisition by Saudi investors, pending EU approval, could significantly impact shareholder value, while consistent cash flow from operations supports dividend stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Electronic Arts Inc.
EA is one of the world's largest third-party video game publishers and has transitioned from a console-based video game publisher to the one of the largest publishers on consoles, PC, and mobile. The firm owns number of large franchises, including Madden, FIFA, Battlefield, Apex Legends, Mass Effect, Dragon's Age, and Need for Speed.
Read more on EA →
